Finch Therapeutics Group Inc Stock News
$10.87
4.96%
Nasdaq,
Dec 27, 03:30 pm CET
Finch Therapeutics Group Inc Stock News
Neutral
GlobeNewsWire
●
2 months ago
BOSTON, Oct. 21, 2024 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (Nasdaq: FNCH) (“Finch” or the “Company”), a microbiome technology company with a portfolio of intellectual property and microbiome assets, today announced that it has provided notification to The Nasdaq Stock Market, LLC (“Nasdaq”) of its intent to delist the Company's common stock, par value $0.001 per share (the “Common...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
